Mitochondria-targeted half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468

To reduce the side effects of marketed cancer drugs against triple negative breast cancer cells we have reported mitochondria targeting half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes for MDA-MB-468 cell therapy and diagnosis. Out of five Ir(iii) complexes (IrL1–IrL5), [iridium(ii...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondal, Ashaparna, Shanavas, Shanooja, Sen, Utsav, Das, Utpal, Roy, Nilmadhab, Bose, Bipasha, Paira, Priyankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016803/
https://www.ncbi.nlm.nih.gov/pubmed/35481100
http://dx.doi.org/10.1039/d2ra01036d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016803/
https://www.ncbi.nlm.nih.gov/pubmed/35481100
http://dx.doi.org/10.1039/d2ra01036d

Ejemplares similares